Cargando…

New Trends in the Detection of Gynecological Precancerous Lesions and Early-Stage Cancers

SIMPLE SUMMARY: This review deals with the prospects of early diagnostics in cervical, endometrial, and ovarian cancers. Progress in cancer research has enabled the rapid development of cancer diagnostics, treatments, and preventions. Indeed, the current situation in genital tract tumors reflects th...

Descripción completa

Detalles Bibliográficos
Autores principales: Holcakova, Jitka, Bartosik, Martin, Anton, Milan, Minar, Lubos, Hausnerova, Jitka, Bednarikova, Marketa, Weinberger, Vit, Hrstka, Roman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699592/
https://www.ncbi.nlm.nih.gov/pubmed/34944963
http://dx.doi.org/10.3390/cancers13246339
_version_ 1784620550280183808
author Holcakova, Jitka
Bartosik, Martin
Anton, Milan
Minar, Lubos
Hausnerova, Jitka
Bednarikova, Marketa
Weinberger, Vit
Hrstka, Roman
author_facet Holcakova, Jitka
Bartosik, Martin
Anton, Milan
Minar, Lubos
Hausnerova, Jitka
Bednarikova, Marketa
Weinberger, Vit
Hrstka, Roman
author_sort Holcakova, Jitka
collection PubMed
description SIMPLE SUMMARY: This review deals with the prospects of early diagnostics in cervical, endometrial, and ovarian cancers. Progress in cancer research has enabled the rapid development of cancer diagnostics, treatments, and preventions. Indeed, the current situation in genital tract tumors reflects the trend in contemporary oncology that emphasizes cancer prevention and early diagnostics. Cervical cancer screening using cytological examination has a long tradition, is highly effective, and is now being complemented with HPV triage, allowing early diagnostics even in precancerous stages due to the relative ease of accessibility of the uterine cervix. Moreover, vaccination against HPV, which is major cause of cervical cancer, is now recommended for both girls and boys at an early age. In contrast, endometrial and, particularly, ovarian cancers are poorly accessible by sampling, and neither prevention nor screening methods readily exist. Thus, other options leading to their early diagnostics are discussed, in which circulating biomarkers play key roles. ABSTRACT: The prevention and early diagnostics of precancerous stages are key aspects of contemporary oncology. In cervical cancer, well-organized screening and vaccination programs, especially in developed countries, are responsible for the dramatic decline of invasive cancer incidence and mortality. Cytological screening has a long and successful history, and the ongoing implementation of HPV triage with increased sensitivity can further decrease mortality. On the other hand, endometrial and ovarian cancers are characterized by a poor accessibility to specimen collection, which represents a major complication for early diagnostics. Therefore, despite relatively promising data from evaluating the combined effects of genetic variants, population screening does not exist, and the implementation of new biomarkers is, thus, necessary. The introduction of various circulating biomarkers is of potential interest due to the considerable heterogeneity of cancer, as highlighted in this review, which focuses exclusively on the most common tumors of the genital tract, namely, cervical, endometrial, and ovarian cancers. However, it is clearly shown that these malignancies represent different entities that evolve in different ways, and it is therefore necessary to use different methods for their diagnosis and treatment.
format Online
Article
Text
id pubmed-8699592
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-86995922021-12-24 New Trends in the Detection of Gynecological Precancerous Lesions and Early-Stage Cancers Holcakova, Jitka Bartosik, Martin Anton, Milan Minar, Lubos Hausnerova, Jitka Bednarikova, Marketa Weinberger, Vit Hrstka, Roman Cancers (Basel) Review SIMPLE SUMMARY: This review deals with the prospects of early diagnostics in cervical, endometrial, and ovarian cancers. Progress in cancer research has enabled the rapid development of cancer diagnostics, treatments, and preventions. Indeed, the current situation in genital tract tumors reflects the trend in contemporary oncology that emphasizes cancer prevention and early diagnostics. Cervical cancer screening using cytological examination has a long tradition, is highly effective, and is now being complemented with HPV triage, allowing early diagnostics even in precancerous stages due to the relative ease of accessibility of the uterine cervix. Moreover, vaccination against HPV, which is major cause of cervical cancer, is now recommended for both girls and boys at an early age. In contrast, endometrial and, particularly, ovarian cancers are poorly accessible by sampling, and neither prevention nor screening methods readily exist. Thus, other options leading to their early diagnostics are discussed, in which circulating biomarkers play key roles. ABSTRACT: The prevention and early diagnostics of precancerous stages are key aspects of contemporary oncology. In cervical cancer, well-organized screening and vaccination programs, especially in developed countries, are responsible for the dramatic decline of invasive cancer incidence and mortality. Cytological screening has a long and successful history, and the ongoing implementation of HPV triage with increased sensitivity can further decrease mortality. On the other hand, endometrial and ovarian cancers are characterized by a poor accessibility to specimen collection, which represents a major complication for early diagnostics. Therefore, despite relatively promising data from evaluating the combined effects of genetic variants, population screening does not exist, and the implementation of new biomarkers is, thus, necessary. The introduction of various circulating biomarkers is of potential interest due to the considerable heterogeneity of cancer, as highlighted in this review, which focuses exclusively on the most common tumors of the genital tract, namely, cervical, endometrial, and ovarian cancers. However, it is clearly shown that these malignancies represent different entities that evolve in different ways, and it is therefore necessary to use different methods for their diagnosis and treatment. MDPI 2021-12-17 /pmc/articles/PMC8699592/ /pubmed/34944963 http://dx.doi.org/10.3390/cancers13246339 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Holcakova, Jitka
Bartosik, Martin
Anton, Milan
Minar, Lubos
Hausnerova, Jitka
Bednarikova, Marketa
Weinberger, Vit
Hrstka, Roman
New Trends in the Detection of Gynecological Precancerous Lesions and Early-Stage Cancers
title New Trends in the Detection of Gynecological Precancerous Lesions and Early-Stage Cancers
title_full New Trends in the Detection of Gynecological Precancerous Lesions and Early-Stage Cancers
title_fullStr New Trends in the Detection of Gynecological Precancerous Lesions and Early-Stage Cancers
title_full_unstemmed New Trends in the Detection of Gynecological Precancerous Lesions and Early-Stage Cancers
title_short New Trends in the Detection of Gynecological Precancerous Lesions and Early-Stage Cancers
title_sort new trends in the detection of gynecological precancerous lesions and early-stage cancers
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699592/
https://www.ncbi.nlm.nih.gov/pubmed/34944963
http://dx.doi.org/10.3390/cancers13246339
work_keys_str_mv AT holcakovajitka newtrendsinthedetectionofgynecologicalprecancerouslesionsandearlystagecancers
AT bartosikmartin newtrendsinthedetectionofgynecologicalprecancerouslesionsandearlystagecancers
AT antonmilan newtrendsinthedetectionofgynecologicalprecancerouslesionsandearlystagecancers
AT minarlubos newtrendsinthedetectionofgynecologicalprecancerouslesionsandearlystagecancers
AT hausnerovajitka newtrendsinthedetectionofgynecologicalprecancerouslesionsandearlystagecancers
AT bednarikovamarketa newtrendsinthedetectionofgynecologicalprecancerouslesionsandearlystagecancers
AT weinbergervit newtrendsinthedetectionofgynecologicalprecancerouslesionsandearlystagecancers
AT hrstkaroman newtrendsinthedetectionofgynecologicalprecancerouslesionsandearlystagecancers